Articles: chronic.
-
BronchiectasisSESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: To assess the effectiveness of inhaled colistin in elderly patients with bronchiectasis and chronic bronchial PA infection in reducing hospital readmissions ⋯ The following authors have nothing to disclose: Eva Tabernero, Pilar Gil, Ramon Alkiza, Javier Garros, Anibal Hernandez, Juan Luis ArtolaNo Product/Research Disclosure Information.
-
Cardiovascular Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Cafergot is an ergotamine commonly prescribed to treat migraine headaches. As a serotonin agonist, it works at 5-HT2B receptors to cause selective vasoconstriction. In this case, a 62 YO WF who had been taking Cafergot for 15 years developed sudden onset transudative recurrent pleural effusions, all common causes ruled out by negative cytology, chemistry, culture, and cell count. She eventually developed severe multiple valvulopathy, pulmonary hypertension, and congestive hepatopathy. This case is unique in its presentation with recurrent pleural effusions of unknown etiology, with delayed diagnosis of ergotamine-induced valvulopathy given its slow progression. ⋯ The following authors have nothing to disclose: Rachel Felber, Hassan BencheqrounNo Product/Research Disclosure Information.
-
Bronchiectasis PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Bronchiectasis is a heterogeneous disease with a wide range of etiological factors and associated conditions. Limited data are available regarding differences of bronchiectasis etiology in different age groups. Our aim was to describe the differences in etiologies and comorbidities related to bronchiectasis between elderly (≥ 60 years) and younger patients. ⋯ The following authors have nothing to disclose: Paola Faverio, Diego Maselli, Alejandro Arango, Juan Fernandez, Marcos RestrepoNo Product/Research Disclosure Information.
-
Pulmonary and Sleep MedicineSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: Intermittent hypoxia and increase sympathetic activity during apnea episodes may cause systemic inflammation via down-regulation of regulatory T-cell (Treg cells). This may contribute to premature atherosclerosis leading to an increase in the size of arterial intima-media thickness (IMT). To evaluate the relationship between Treg plasma cells and intima-media thickness (IMT) in non-OSA and OSA patients without comorbidities ⋯ The effect of nocturnal intermittent hypoxia and increase sympathetic activity is not homogeneous among all patients with OSA. It seems that a subset of patients exhibit an increased risk of subclinical atherosclerosis associated with a down-regulation of regulatory T-cells. This subgroup of patients probably represents a particular phenotypic presentation of OSA that merits a specific treatment. Supported by ISCIII grant PI12/02175 and SEPAR-2014DISCLOSURE: The following authors have nothing to disclose: Marta Marin-Oto, Teresa Martin, Javier Godino, Marta Andres, Victoria Gil, Jose MarinNo Product/Research Disclosure Information.
-
Infectious Disease Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: The most common autoimmune inflammatory demyelinating disease of the central nervous system is multiple sclerosis. It has a unique clinical feature of unpredictable exacerbations and remissions. Systemic infectious process is one of the important precipitating factors for multiple sclerosis exacerbation1. ⋯ Our case report reflects the association of a multiple sclerosis exacerbation with an underlying infectious process. The patient's neurological findings significantly improved following treatment of the empyema. Early detection and adequate treatment of systemic infection is a cornerstone of multiple sclerosis exacerbation management.Reference #1: Buljevac D, Flach HZ, et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain. 2002;125(Pt 5):952-960Reference #2: Correale J, Fiol M, et al. The risk of relapses in multiple sclerosis during systemic infections. Neurology. 2006;67(4):652-659DISCLOSURE: The following authors have nothing to disclose: Debjit Saha, Jillian Cepeda, Daisha Hayden, Ari CimentNo Product/Research Disclosure Information.